Link to article on Factset Insight: https://insight.factset.com/investors-and-traders-need-to-track-prescription-drug-user-fee-act-pdufa-content
Summary:
PDUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the U.S. Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market.
Related Content
-
Mid-Quarter Investor Conference Calendar: Stocks Heat Up Heading Into Autumn
-
From Classrooms to Wall Street: Why Back-to-School Matters More This Year
-
Divided Tech, Divided Fed: Navigating AI Capex Scrutiny and Mixed Macro Signals
-
AI Capex Hits a Tipping Point as Investors Demand More Corporate Discipline
-
The AI Capex Warning: Alphabet Sets a Tense Stage for Amazon, Microsoft, and Meta
-
Mild Macro Data Sets up AI Tech Earnings and a Busy August Corporate Event Stretch
-
A Stellar Start: Big Banks Defy Credit Fears to Kick Off Q2 Earnings
-
SaaSpocalypse Part II? IBM’s Preliminary Earnings Report Rattles Software
-
Q2 2026 Earnings Preview: Navigating High Expectations, Tariff Rebates, and War Uncertainties
-
Q3 2026 Investor Conference Calendar: Taking Stock of Major Industry Themes... And Risks
